Regeneron/Sanofi Offer Free Praluent Samples To Counter Slow Coverage
This article was originally published in The Pink Sheet Daily
Executive Summary
Ten days post the US launch of closely-watched Praluent, Regeneron said it plans to distribute free samples of the drug in response to slow reimbursement decisions.